Free Trial
→ Trump’s Exec Order #14154 could be a “Millionaire-Maker” (From Paradigm Press) (Ad) Free APVO Stock Alerts

Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume

Aptevo Therapeutics logo
$3.03 +0.05 (+1.68%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.03 0.00 (0.00%)
As of 07/18/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Aptevo Therapeutics Short Interest Data

Aptevo Therapeutics (APVO) has a short interest of 164,700 shares, representing 5.60% of the float (the number of shares available for trading by the public). This marks a 1,344.74% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 613,104 shares to cover all short positions.

Current Short Interest
164,700 shares
Previous Short Interest
11,400 shares
Change Vs. Previous Month
+1,344.74%
Dollar Volume Sold Short
$502.34 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
760,000 shares
Float Size
2,940,000 shares
Short Percent of Float
5.60%
Today's Trading Volume
198,444 shares
Average Trading Volume
613,104 shares
Today's Volume Vs. Average
32%
Short Selling Aptevo Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

APVO Short Interest Over Time

APVO Days to Cover Over Time

APVO Percentage of Float Shorted Over Time

Aptevo Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2025164,700 shares $502.34 thousand +1,344.7%5.6%0.1 $3.05
6/15/202511,400 shares $50.05 thousand +21.3%1.5%0 $4.39
5/31/20259,400 shares $44.65 thousand -55.0%1.4%0 $4.75
5/15/202520,900 shares $6.90 thousand -95.4%1.4%0.1 $0.33
4/30/2025452,300 shares $239.72 thousand -35.7%N/A0.2 $0.53
4/15/2025703,600 shares $675.46 thousand +82.0%23.3%0.3 $0.96
3/31/2025386,500 shares $448.34 thousand +220.5%12.0%0.2 $1.16
3/15/2025120,600 shares $290.65 thousand +100.7%8.3%1.8 $2.41
2/28/202560,100 shares $229.58 thousand +155.7%4.1%0.3 $3.82
2/15/202523,500 shares $78.49 thousand -46.2%1.6%0.1 $3.34
1/31/202543,700 shares $191.41 thousand +64.9%3.0%0.2 $4.38
1/15/202526,500 shares $120.58 thousand +39.5%1.8%0.1 $4.55
12/31/202419,000 shares $81.89 thousand -92.1%1.3%0.1 $4.31
12/15/2024241,700 shares $988.55 thousand +536.1%16.6%0.8 $4.09
11/30/202438,000 shares $14.57 million -94.8%7.6%0.2 $383.32
11/15/2024734,600 shares $155.00 thousand -38.8%N/A0.1 $0.21
10/31/20241,200,000 shares $323.88 thousand +675.7%N/A0.2 $0.27
10/15/2024154,700 shares $22.42 thousand +164.9%N/A0 $0.14
9/30/202458,400 shares $10.50 thousand +349.2%N/A0 $0.18
9/15/202413,000 shares $4.61 thousand -78.8%N/A0 $0.35
8/31/202461,400 shares $22.10 thousand -80.2%N/A0 $0.36
8/15/2024310,700 shares $135.15 thousand -54.8%N/A0.1 $0.44
7/31/2024687,500 shares $277.27 thousand +2.9%N/A0.1 $0.40
7/15/2024668,300 shares $203.97 thousand +91.7%N/A0.1 $0.31
6/30/2024348,700 shares $106.70 thousand +1,552.6%N/A0.4 $0.31
6/15/202421,100 shares $16.20 thousand -55.8%0.5%0 $0.77
5/31/202447,700 shares $33.99 thousand -11.7%1.2%0.1 $0.71
5/15/202454,000 shares $43.63 thousand -79.9%1.3%0.1 $0.81
4/30/2024268,200 shares $190.61 thousand +84.2%16.8%0.3 $0.71
4/15/2024145,600 shares $114.00 thousand +324.5%9.1%0.6 $0.78
3/31/202434,300 shares $160.87 thousand +18.7%5.1%0.3 $4.69
3/15/202428,900 shares $156.64 thousand +725.7%5.5%0.3 $5.42
2/29/20243,500 shares $26.18 thousand -82.1%N/A0 $7.48
2/15/202419,600 shares $3.08 thousand +17.4%N/A0.1 $0.16
1/31/202416,700 shares $2.72 thousand -78.8%N/A0 $0.16
1/15/202478,900 shares $12.55 thousand -61.3%N/A0.2 $0.16
12/31/2023203,900 shares $36.91 thousand +253.4%N/A0.3 $0.18
12/15/202357,700 shares $9.92 thousand -46.0%N/A0.1 $0.17
11/30/2023106,800 shares $19.97 thousand +297.0%N/A0.2 $0.19
11/15/202326,900 shares $4.98 thousand -74.2%N/A0.1 $0.19
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
10/31/2023104,300 shares $29.49 thousand -19.3%N/A0.2 $0.28
10/15/2023129,200 shares $41.34 thousand +7.4%N/A0.3 $0.32
9/30/2023120,300 shares $39.70 thousand +161.5%N/A0.4 $0.33
9/15/202346,000 shares $18.45 thousand -46.6%N/A0.1 $0.40
8/31/202386,200 shares $37.93 thousand +176.3%N/A0.3 $0.44
8/15/202331,200 shares $11.54 thousand -97.8%N/A0.1 $0.37
7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04
7/15/202335,300 shares $52.95 thousand +13.1%N/A0.2 $1.50
6/30/202331,200 shares $45.55 thousand +51.5%N/A0.6 $1.46
6/15/202320,600 shares $32.96 thousand -59.7%N/A0.4 $1.60
5/31/202351,100 shares $79.72 thousand -28.0%N/A1 $1.56
5/15/202371,000 shares $117.15 thousand -47.6%N/A1.3 $1.65
4/30/2023135,500 shares $260.16 thousand +47.8%N/A2.4 $1.92
4/15/202391,700 shares $174.23 thousand -35.1%N/A1.6 $1.90
3/31/2023141,200 shares $287.34 thousand +34.2%N/A2 $2.04
3/15/2023105,200 shares $190.41 thousand -30.1%N/A1.2 $1.81
2/28/2023150,400 shares $318.85 thousand +118.6%N/A0.2 $2.12
2/15/202368,800 shares $141.04 thousand -49.1%N/A0.1 $2.05
1/31/2023135,100 shares $310.73 thousand -27.3%N/A0.2 $2.30
1/15/2023185,800 shares $418.05 thousand -32.3%N/A0.2 $2.25
12/30/2022274,500 shares $636.84 thousand -38.8%N/A0.4 $2.32
12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25
11/30/202251,900 shares $161.93 thousand -2.8%N/A1.5 $3.12
11/15/202253,400 shares $178.89 thousand -12.3%N/A1.5 $3.35
10/31/202260,900 shares $183.92 thousand +6.8%N/A1.3 $3.02
10/15/202257,000 shares $161.31 thousand +8.6%N/A0.9 $2.83
9/30/202252,500 shares $159.60 thousand +23.8%N/A0.9 $3.04
9/15/202242,400 shares $158.58 thousand +3.9%N/A0.7 $3.74
8/31/202240,800 shares $144.43 thousand -4.5%N/A0.4 $3.54
8/15/202242,700 shares $195.99 thousand -48.9%N/A0.5 $4.59
7/31/202283,500 shares $328.99 thousand -9.3%N/A1 $3.94
7/15/202292,100 shares $361.03 thousand -30.2%N/A1.3 $3.92
6/30/2022132,000 shares $472.56 thousand -24.8%N/A1.4 $3.58
6/15/2022175,600 shares $579.48 thousand +20.9%N/A0.8 $3.30
5/31/2022145,200 shares $665.02 thousand +1.0%N/A0.7 $4.58
5/15/2022143,700 shares $661.02 thousand -13.4%N/A0.7 $4.60
4/30/2022165,900 shares $706.73 thousand -12.2%N/A0.7 $4.26
4/15/2022188,900 shares $899.16 thousand -6.3%N/A0.7 $4.76
3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87
3/15/2022144,500 shares $647.36 thousand +1.4%N/A1 $4.48
2/28/2022142,500 shares $820.80 thousand -19.4%N/A0.6 $5.76
2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29
1/31/202250,900 shares $297.26 thousand -65.8%N/A0 $5.84
1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22
12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87
12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90
11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96
11/15/202187,300 shares $848.56 thousand +4.9%N/A0 $9.72
10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24
10/15/202162,900 shares $942.87 thousand +4.7%N/A1.4 $14.99
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
9/30/202160,100 shares $927.94 thousand -6.1%N/A1.2 $15.44
9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14
8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95
8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00
7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77
7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75
6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43
6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00
5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12
5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93
4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34
4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57
3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20
3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97
2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62
2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76
1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83
1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82
12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11
12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61
11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39
11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98
10/30/202086,900 shares $572.67 thousand +2.4%3.0%0.1 $6.59
10/15/202084,900 shares $594.30 thousand -15.1%3.0%1.6 $7.00
9/30/2020100,000 shares $760 thousand +33.7%3.5%1.2 $7.60
9/15/202074,800 shares $596.16 thousand +9.2%2.6%0.1 $7.97
8/31/202068,500 shares $537.04 thousand -20.3%2.4%0.1 $7.84
8/14/202085,900 shares $684.62 thousand +39.7%3.0%0.1 $7.97
7/31/202061,500 shares $516.60 thousand +27.6%2.1%0.1 $8.40

APVO Short Interest - Frequently Asked Questions

What is Aptevo Therapeutics' current short interest?

Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 164,700 shares of APVO short. 5.60% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest.

What is a good short interest percentage for Aptevo Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.60% of Aptevo Therapeutics' floating shares are currently sold short.

Is Aptevo Therapeutics' short interest increasing or decreasing?

Aptevo Therapeutics saw a increase in short interest in June. As of June 30th, there was short interest totaling 164,700 shares, an increase of 1,344.7% from the previous total of 11,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Aptevo Therapeutics' float size?

Aptevo Therapeutics currently has issued a total of 760,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 2,940,000 shares.

How does Aptevo Therapeutics' short interest compare to its competitors?

5.60% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Moleculin Biotech, Inc. (15.64%), Lixte Biotechnology Holdings, Inc. (8.49%), Chromocell Therapeutics Co. (8.70%), X4 Pharmaceuticals, Inc. (5.15%), Traws Pharma, Inc. (4.99%), Evoke Pharma, Inc. (0.84%), Turnstone Biologics Corp. (0.52%), Biofrontera Inc. (2.26%), Biomerica, Inc. (2.00%), Cardio Diagnostics Holdings, Inc. (2.61%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Aptevo Therapeutics stock?

Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aptevo Therapeutics?

A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further.

How often is Aptevo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is June, 30 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:APVO) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Turn $1K into $50K with This DeFi Gem
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...
Crypto 101 Media | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored